ARTICLE | Company News
CryoLife other research news
August 29, 1994 7:00 AM UTC
The Atlanta company received a $75,000 Phase I SBIR grant from the NIH's National Heart, Lung and Blood Institute to develop SynerGraft, a bioengineered tissue human heart valve. SynerGraft is designe...